The role of MAP kinases in trauma and ischemia-reperfusion

Journal of Investigative Surgery

Volumn 17, Issue 1, 2004, Pages 45-53

  Lai, Edwin W ^a   Toledo Pereyra, Luis ^a,b   Walsh, John ^c   Lopez Neblina, F ^c   Anaya Prado, R ^c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c Borgess Research Institute   (United States)

Author keywords

ERK; Ischemia reperfusion; MAPKs; p38; SAP JNK; Trauma

Indexed keywords

ANTIINFLAMMATORY AGENT; AUTACOID; CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

DRUG TARGETING; HEMORRHAGIC SHOCK; HUMAN; INFLAMMATION; INFLAMMATORY CELL; ISCHEMIA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; REPERFUSION INJURY; WOUNDS AND INJURIES;

EID: 1542359663     PISSN: 08941939     EISSN: None     Source Type: Journal    
DOI: 10.1080/08941930490269646     Document Type: Review

References (59)

1. Holzheimer RG, Gross J, Schein M. Pro- and anti-inflammatory cytokine-response in abdominal aortic aneurysm repair: A clinical model of ischemia-reperfusion. Shock. 1999;11:305-310.
2. Oberholzer A, Oberholzer C, Moldawer LL. Cytokine signaling - Regulation of the immune response in normal and critically ill states. Crit Care Med. 2000;28:3-12.
3. Yaffe MB, Fink MP. Cellular signaling in critical care - Putting the pieces together. Crit Care Med. 2000;28:1-2.
4. Hu Y, Cheng L, Hochleitner BW, Xu O. Activation of mitogen-activated protein kinase (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arterioscler Thrombos Vasc Biol. 1997;17:2808-2816.
5. Mendez C, Jaffray C, Wong V, Salhab KF, Kramer AA, Carey LC, Norman JG. Involvement of p38 mitogen-activated protein kinase in the induction of tolerance to hemorrhagic and endotoxic shock. J Surg Res. 2000;91:165-170.
6. Junger WG, Hoyt DB, Hamreus M, Liu FC, Herdon-Remelius C, Junger W, Altman A. Hypertonic saline activates protein tyrosine kinases and mitogen-activated protein kinase p38 in T-cells. J Trauma. 1997;42:437-445.
7. Sun Z, Andersson R. NF-κB Activation and inhibition: A review. Shock. 2002;18:99-106.
8. Carter AB, Monick MM, Hunninghake GW. Both Erk and p38 are necessary for cytokine gene transcription. Am J Respir Cell Mol Biol. 1999;20:751-758.
9. Boyle EM Jr., Pohlman TH, Johnson MC, Verrier ED. Endotheral cell injury in cardiovascular surgery: The systemic inflammatory response. Ann Thorac Surg. 1997;63:277-284.
10. Steenbergen C. The role of p38 mitogen-activated protein kinase in myocardial ischemia/reperfusion injury: Relationship to ischemia preconditioning. Basic Res Cardiol. 2002;97:276-285.
11. Obata T, Brown GE, Yaffe MB. MAP Kinase pathways activated by stress: The p38 MAPK pathway. Crit Care Med. 2000;28:67-77.
12. Ma XL, Kumar S, Gao F, Louden CS, Lopez BL, Christopher TA, et al. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ishemia and reperfusion. Circulation. 1999;99:1685-1691.
13. Mackay K, Mochly-Rosen D. An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia. J Biol Chem. 1999;274:6272-6279.
14. Amersi F, Shen XD, Anselmo D, Melinek J, Iyer S, Southard DJ, et al. Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology. 2002;35:815-823.
15. Kobayashi M, Takeyoshi I, Yoshinari D, Matsumoto K, Morishita Y. P38 mitogen-activated protein kinase inhibition attenuates ischemia-reperfusion injury of the rat liver. Surgery. 2002;131:344-349.
16. Teoh N, Pena AD, Farrell G. Hepatic ischemia preconditioning in mice is associated with activation of NF-κB, p38 kinase, and cell cycle entry. Hepatology. 2002;36:94-102.
17. Lennmyr F. Signal transduction in focal cerebral ischemia: Experimental studies on VEGF, MAPK and Src family kinases. 2002; http://publications.uu.se/theses/fulltext/91-554-5267-1.pdf (2002-08-08).
18. Mannick JA, Rodrick ML, Lederer JA. The immunologic response to injury. J Am Coll Surg. 2001;193:237-244.
19. Martinez-Mier G, Toledo-Pereya LH, Ward PA. Adhesion molecules and hemorrhagic shock. J Trauma. 2001;51:408-415.
20. Rehring TF, Brew EC, Friese RS, Banergee A, Harken AH. Clinically accessible cell signaling: Second messengers in sepsis and trauma. J surg res. 1996;60:270-277.
21. Hoyt DB. What's new in general surgery: Trauma and critical care. J Am Coll Surg. 2002;194:335-351.
22. Martinez-Mier G, Toledo-Pereyra LH, Ward PA. Adhesion molecules in liver ischemia and reperfusion. J Surg Res. 2000;94:185-194.
23. Pombo CM, Bonventre JV, Avruch J, Woodgett JR, Kyriakis JM. The stress-activated protein kinases are major c-Jun amino-terminal kinases activated by ischemia and reperfusion. J Biol Chem. 1994;269:26546-26551.
24. diMari JF, Davis R, Safirstein RL. MAPK activation determines renal epithelial cell survival during oxidative injury. Am J Physiol. 1999;277:F195-203.
25. Sodhi CP, Batlle D, Sahai A. Osteopontin mediates hypoxia-induced proliferation of cultured mesangial cells: Role of PKC and p38 MAPK. Kidney Int. 2000;58:691-700.
26. Martinez-Mier G, Toledo-Pereyra LH, McDuffie JE, Warner RL, Hsiao C, Stapleton SR, Ward PA. Exogenous nitric oxide downregulates MIP-2 and MIP-1 alpha chemokines and MAPK p44/42 after ischemia and reperfusion of the rat kidney. J Invest Surg. 2002;15:287-296.
27. Knight RJ, Buxton DB. Stimulation of c-Jun kinase and mitogen-activated protein kinase by ischemia and reperfusion in the perfused rat heart. Biochem Biophys Res Commun. 1996;218:83-89.
28. Bogoyevitch MA, Gillespie-Brown J, Ketterman AJ, Fuller SJ, Ben-Levy R, Ashworth A, Marshall CJ, Sugden PH. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in rerfused heart. P38/RK mitogen-activiated protein kinases and c-jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res. 1996;79:162-173.
29. Mizukami Y, Yoshioka K, Morimoto S, Yoshida K. A novel mechanism of JNK1 activation. Nuclear translocation and activation of JNK1 during ischemia and reperfusion. J Biol Chem. 1997;272:16657-16662.
30. Weinbrenner C, Liu GS, Cohen MV, Downey JM. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart, J Mol Cell Cardiol. 1997;29:16657-16662.
31. Clerk A, Fuller SJ, Micahel A, Sugden PH. Stimulation of "stress-regulated" mitogen-activiated protein kinases (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses. J Biol Chem. 1998;273:7228-7234.
32. Shimizu N, Yoshiyama M, Omura T, Hanatani A, Kim S, Takeuchi K, Iwao H, Yoshikawa J. Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats. Cardiovasc Res. 1998;38:116-124.
33. Nagarkatti DS, Sha'afi RI. Role of p38 MAP kinase in myocardial stress. J Mol Cell Cardiol. 1998;30:1651-1664.
34. Cain BS, Meldrum DR, Meg X, Dinarello CA, Chames BD, Banejee A, Harken AH. p38 MAPK inhibition decreases TNF-alpha production and enhances postischemic human myocardial function. J Surg Res. 1999;83:7-12.
35. Pin P, Zhang J, Cao X, Li RC, Kong D, Tang XL, Qiu Y, Manchikalapudi S, Auchampach JA, Black RG, Bolli R. PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. Am J Physiol. 1999;276 (pt2):H1468-1481.
36. Nakano A, Baines CP, Kim SO, Pelech SL, Downey JM, Cohen MV, Critz SD. Ischemic preconditioning activation MAPKAPK2 in the isolated rabbit heart: Evidence for involvement of p38MAPK. Circ Res. 2000;77:559-567.
37. Abe J, Baines CP, Berk BC. Role of mitogen-activated protein kinases in ischemia and reperfusion injury: The good and the bad. Circ Res. 2000;86:692-699.
38. Negoro S, Kunisada K, Tone E, Funamoto M, Oh H, Kishimoto T, Yamuchi-Takihara K. Activation of JAK/STAT pathway tranduces cytoprotective signal in rat acute myocardial infarction. Cardiovasc Res. 2000;47:797-805.
39. Tekin D, Xi L, Zhao T, Tejero-Taldo MI, Atluri S, Kukreja RC. Mitogen-activated protein kinases mediate heat shock-induced delayed protection in mouse heart. Am J Physiol Heart Circ Physiol. 2001;281:H523-H532.
40. Schulz R, Belosjorow S, Gres P, Jansen J, Michel MC, Heusch G. p38 MAP kinase is a mediator of ischemic preconditioning in pigs. Cardiovasc Res. 2002;55: 690-700.
41. Otsu K, Yamashita N, Nishida K, Hirotani S, Yamaguchi O, Watanabe T, Hikoso S, Higuchi Y, Matsumura Y, Maruyama M, Sudo T, Osada H, Hori M. Disruption of a single copy of the p38alpha MAP kinase gene leads to cardioprotection against ischemia-reperfusion. Biochem Biophys Res Commun. 2003;302:56-60.
42. Sturgill TW, Ray LB. Muscle proteins related to microtubule associated protein-2 are substrates for an insulin-stimulated kinase. Biochem Biophys Res Commun. 1986;134:565-571.
43. Kyriakis JM, Avruch J. S6 kinases and MAP kinases: Sequential intermediates in insulin/mitogen-activated protein kinase cascades. In: Woodgett JR, ed. Protein Kinases. New York: Oxford University Press; 1994;85-148.
44. Kyriakis JM. Mammalian MAP kinase pathways. In: Woodgett, J, ed. Protein Kinase Functions. New York: Oxford University Press; 2000;40-158.
45. Manning AM, Rao A. Agents targeting transcription factors. In: Gallin JI, et al., eds. Inflammation. Philadelphia: Lippincott Williams & Wilkins; 1999;1159-1176.
46. Rosengart MR, Arbabi S, Garcia I, et al. Interactions of calcium/calmodulin-dependent protein kinases (CaMK) and extracellular-regulated kinase (ERK) in monocyte adherence and TNF alpha production. Shock. 2000;13:183-189.
47. Vaagenes P, Gundersen Y, Myhre O, Andersen JM, et al. Early treatment with hydrocortisone and/or U0126 inhibits the synthesis of reactive oxygen species (ROS) after gunshot injuries in pigs. Prehosp Disast Med. 2002;17.
48. Gosh S, Karin M. Missing pieces in the NF-KB puzzle. Cell. 2002;109:581-596.
49. Shackelford DA, Yeh RY. Differential effects of ischemia and reperfusion on c-Jun N-terminal kinase isoform protein and activity. Mol Brain Res. 2001;94:178-192.
50. Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 1994;265:808-811.
51. Bruggen T, Nijenhuis S, Raaij E, Verhoef J, Asbeck BS. Lipopolysaccharide-induced tumor necrosis factor alpha production by human monocytes involves the Raf-1/MEK1-MEK2/ERK1-ERK2 pathway, Infect Immun. 1999;67:3824-3829.
52. Keane MP, Strieter RM. Chemokine signaling in inflammation. Crit Care Med. 2000;28:13-26.
53. Yoshinari D, Takeyoshi I, Koibuchi Y, Matsumoto K, et al. Effects of a dual inhibitor of tumor necrosis factor-α and interleukin-1 on lipopolysaccharide-induced lung injury in rats: Involvement of the p38 mitogen-activated protein kinase pathway. Crit Care Med. 2001;29:628-634.
54. Sheth K, Friel J, Nolan B, Bankey P. Inhibition of p38 mitogen activated protein kinase increases lipopolysaccharide induced inhibition of apoptosis in neurophils by activating extracellular signal-regulated kinase. Surgery. 2001;130:242-248.
55. Park HJ, Kim BC, Kim SJ, Choi KS. Role of MAP kinases and their cross-talk in TGF-β1-induced apoptosis in FaO rat hepatoma cell line. Hepatology. 2002;35:1360-1371.
56. Gupta S. Molecular steps of tumor necrosis factor receptor-mediated apoptosis. Curr Mol Med. 2001;1:317-324.
57. Swartbol P, Truedsson L, Norgren L. The inflammatory response and its consequence for the clinical outcome following aortic aneurysm repair. Eur J Vasc Endovasc Surg. 2001;21:393-400.
58. Khadaroo RG, Lu Z, Powers KA, Papia G, Kapus A, Rotstein OD. Impaired activation of mitogen-activated protein kinases after hemorrhagic shock. Surgery. 2002;132:360-364.
59. Marcizin N, Bundy RE, Hoare GS, Yacoub M. Redox regulation following cardiac ischemia and perferusion. Coronary Artery Dis. 2003;14:123-133.